Literature DB >> 12814189

Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis.

Katsumi Motegi1, Koji Harada, Sima Pazouki, Robin Baillie, Ana M Schor.   

Abstract

Contradictory results have been reported regarding the association between vascularity (used as an index of angiogenesis) and thrombospondin-1 (TSP-1) in human tumours. In previous studies, the reported association was based on the estimated average TSP-1 value per tumour, with a sufficient number of specimens collectively analysed per tumour type. Given the extent of intra-tumour heterogeneity, we determined the association between TSP-1 and vascularity within individual specimens, based on the average values of TSP-1 and vascularity in 10-20 pre-selected areas per tumour. Cells expressing TSP-1 mRNA were visualised by in situ hybridisation and quantified by point counting. Vascularity was quantified by point counting and vessel density of von Willebrand Factor-positive vessels. In 10 ductal breast carcinomas, a direct correlation between TSP-1 and vascularity was found in 4 tumours, no correlation in 3 and an inverse correlation in 3. The effect of TSP-1 on endothelial cell migration in vitro was assessed in the Boyden chamber assay. TSP-1 stimulated cell migration at low concentrations (0.1-10 microg/ml) and was inhibitory at high concentrations (25-100 microg/ml). These results suggest that TSP-1 may elicit a concentration-dependent, bi-phasic, effect on angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12814189     DOI: 10.1023/a:1023687505139

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  8 in total

1.  Two Endogenous Antiangiogenic Inhibitors, Endostatin and Angiostatin, Demonstrate Biphasic Curves in their Antitumor Profiles.

Authors:  Kashi Javaherian; Tong-Young Lee; Robert M Tjin Tham Sjin; George E Parris; Lynn Hlatky
Journal:  Dose Response       Date:  2010-10-21       Impact factor: 2.658

2.  Atorvastatin affects several angiogenic mediators in human endothelial cells.

Authors:  Józef Dulak; Agnieszka Loboda; Agnieszka Jazwa; Anna Zagorska; Jacob Dörler; Hannes Alber; Wolfgang Dichtl; Franz Weidinger; Matthias Frick; Alicja Jozkowicz
Journal:  Endothelium       Date:  2005 Sep-Dec

3.  Estrogen regulation of thrombospondin-1 in human breast cancer cells.

Authors:  Salman M Hyder; Yayun Liang; Jianbo Wu
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

Review 4.  Drug resistance associated with antiangiogenesis therapy.

Authors:  Hans Petter Eikesdal; Raghu Kalluri
Journal:  Semin Cancer Biol       Date:  2009-06-11       Impact factor: 15.707

5.  Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice.

Authors:  Sarah Jenkins; Jun Wang; Isam Eltoum; Renee Desmond; Coral A Lamartiniere
Journal:  Environ Health Perspect       Date:  2011-10-12       Impact factor: 9.031

6.  PPARalpha deficiency in inflammatory cells suppresses tumor growth.

Authors:  Arja Kaipainen; Mark W Kieran; Sui Huang; Catherine Butterfield; Diane Bielenberg; Gustavo Mostoslavsky; Richard Mulligan; Judah Folkman; Dipak Panigrahy
Journal:  PLoS One       Date:  2007-02-28       Impact factor: 3.240

7.  A Hypothesis Concerning the Biphasic Dose-response of Tumors to Angiostatin and Endostatin.

Authors:  George E Parris
Journal:  Dose Response       Date:  2015-05-20       Impact factor: 2.658

8.  Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer.

Authors:  Andrew R Reynolds
Journal:  Dose Response       Date:  2010-04-23       Impact factor: 2.658

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.